Stage III Breast Cancer Recruiting Phase 1 Trials for Onalespib (DB06306)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02474173Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast CancerTreatment